Valuation in M&A: More Art, Less Science? Or Vice Versa?

Valuation in M&A remains one of the most debated aspects of dealmaking. While financial models and data-driven approaches are crucial, dealmakers often find themselves weighing intangibles and human judgment just as heavily.

Ultimately, while the science of valuation gives structure to the process, the art lies in understanding the nuances that numbers alone can’t capture. So—are valuations today leaning more toward science, or is there still room for instinct and interpretation? I’d love to hear your take